BDBM202350 US9238619, 69

SMILES: CN1CCC(Cc2ccccc2)(C1)c1cccc(CNS(=O)(=O)c2cnn(C)c2)c1

InChI Key: InChIKey=MXWWAZZLJCLTPJ-UHFFFAOYSA-N

Data: 1 KI

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 202350   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Sodium- and chloride-dependent glycine transporter 1 (Homo sapiens (Human))	BDBM202350 (US9238619, 69) Show SMILES CN1CCC(Cc2ccccc2)(C1)c1cccc(CNS(=O)(=O)c2cnn(C)c2)c1 Show InChI InChI=1S/C23H28N4O2S/c1-26-12-11-23(18-26,14-19-7-4-3-5-8-19)21-10-6-9-20(13-21)15-25-30(28,29)22-16-24-27(2)17-22/h3-10,13,16-17,25H,11-12,14-15,18H2,1-2H3	PDB KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	<1	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
AbbVie Deutschland GmbH & Co. KG; AbbVie Inc. US Patent					Assay Description Radioligand binding to human GlyT1c transporter-expressing membranes was determined as described in Mezler et al., Molecular Pharmacology 74:1705-171...				US Patent US9238619 (2016) BindingDB Entry DOI: 10.7270/Q2XS5T6F
					More data for this Ligand-Target Pair